Through our approved supplier, we were able to secure a high value Biosimilar drug with good batch expiry and certifications within the time scale allotted for phase III of the customer’s trial. Furthermore, the cost was within the budgeted allowance for the client’s trial. As the manufacturer had limited the supply available, this took some planning from our side, to ensure the same batch for each delivery was supplied through collation procedure.
Cold Chain Products
With constant contact with our supplier and regular updates to the client, we were able to deliver this cold chain product under GDP Temperature Controlled Guidelines to our customer to enable the trial to continue without any delay. A risk assessment was performed on the shipment to ensure any risks were managed effectively.